Home
>
National Drug Code (NDC)
>
Plasma-Lyte A
Plasma-Lyte A - 0338-0221-04 - (Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride)
Drug Information of Plasma-Lyte A
| Product NDC: | 0338-0221 |
| Proprietary Name: | Plasma-Lyte A |
| Non Proprietary Name: | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride |
| Active Ingredient(s): | 30; 37; 368; 526; 502 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL & nbsp; Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Plasma-Lyte A
| Product NDC: | 0338-0221 |
| Labeler Name: | Baxter Healthcare Coporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017378 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19790202 |
Package Information of Plasma-Lyte A
| Package NDC: | 0338-0221-04 |
| Package Description: | 1000 mL in 1 BAG (0338-0221-04) |
NDC Information of Plasma-Lyte A
| NDC Code | 0338-0221-04 |
| Proprietary Name | Plasma-Lyte A |
| Package Description | 1000 mL in 1 BAG (0338-0221-04) |
| Product NDC | 0338-0221 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19790202 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Coporation |
| Substance Name | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE |
| Strength Number | 30; 37; 368; 526; 502 |
| Strength Unit | mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |
